Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Finished Goods: 2022-2025

Historic Finished Goods for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Sep 2025 value amounting to $11.6 million.

  • Arcutis Biotherapeutics' Finished Goods rose 42.14% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year increase of 42.14%. This contributed to the annual value of $9.6 million for FY2024, which is 257.51% up from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Finished Goods is $11.6 million, which was up 47.18% from $7.9 million recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Finished Goods registered a high of $11.6 million during Q3 2025, and its lowest value of $698,000 during Q3 2022.
  • Over the past 3 years, Arcutis Biotherapeutics' median Finished Goods value was $5.8 million (recorded in 2024), while the average stood at $5.7 million.
  • Data for Arcutis Biotherapeutics' Finished Goods shows a peak YoY spiked of 257.51% (in 2024) over the last 5 years.
  • Over the past 4 years, Arcutis Biotherapeutics' Finished Goods (Quarterly) stood at $1.5 million in 2022, then skyrocketed by 84.73% to $2.7 million in 2023, then skyrocketed by 257.51% to $9.6 million in 2024, then soared by 42.14% to $11.6 million in 2025.
  • Its Finished Goods was $11.6 million in Q3 2025, compared to $7.9 million in Q2 2025 and $8.3 million in Q1 2025.